 | • レポートコード：QYR2104Z1292 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、クラミジア感染症診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（核酸増幅検査（NAAT）、直接蛍光検査、マクロライド系抗生物質、キノロン系抗生物質、スルホンアミド系抗生物質、テトラサイクリン系抗生物質、アミノペニシリン系抗生物質）、用途別市場規模（病院、専門クリニック、診断センター治療、病院薬局、ドラッグストア、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クラミジア感染症診断・治療の市場動向 ・企業の競争状況、市場シェア ・クラミジア感染症診断・治療の種類別市場規模（核酸増幅検査（NAAT）、直接蛍光検査、マクロライド系抗生物質、キノロン系抗生物質、スルホンアミド系抗生物質、テトラサイクリン系抗生物質、アミノペニシリン系抗生物質） ・クラミジア感染症診断・治療の用途別市場規模（病院、専門クリニック、診断センター治療、病院薬局、ドラッグストア、小売薬局、オンライン薬局） ・クラミジア感染症診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・クラミジア感染症診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クラミジア感染症診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クラミジア感染症診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・クラミジア感染症診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bio Rad、Novartis、Roche、Abbott、Danaher、BioMerieux、DiaSorin、Siemens、Thermo Fisher、Becton Dickinson） ・結論 |
The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities.
Market Analysis and Insights: Global Chlamydia Infection Diagnostics and Therapeutics Market
The global Chlamydia Infection Diagnostics and Therapeutics market size is projected to reach US$ 1076.9 million by 2026, from US$ 856.4 million in 2019, at a CAGR of 3.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chlamydia Infection Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chlamydia Infection Diagnostics and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chlamydia Infection Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chlamydia Infection Diagnostics and Therapeutics market.
Global Chlamydia Infection Diagnostics and Therapeutics Scope and Market Size
Chlamydia Infection Diagnostics and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chlamydia Infection Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nucleic Acid Amplification Tests (NAATs)
Direct Fluorescent Tests
Macrolides
Quinolones
Sulfonamides
Tetracycline
Aminopenicillins
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers Therapeutics
Hospital Pharmacies
Drugstores
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bio Rad
Novartis
Roche
Abbott
Danaher
BioMerieux
DiaSorin
Siemens
Thermo Fisher
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nucleic Acid Amplification Tests (NAATs)
1.2.3 Direct Fluorescent Tests
1.2.4 Macrolides
1.2.5 Quinolones
1.2.6 Sulfonamides
1.2.7 Tetracycline
1.2.8 Aminopenicillins
1.3 Market by Application
1.3.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers Therapeutics
1.3.5 Hospital Pharmacies
1.3.6 Drugstores
1.3.7 Retail Pharmacies
1.3.8 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Perspective (2016-2027)
2.2 Chlamydia Infection Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chlamydia Infection Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Chlamydia Infection Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Chlamydia Infection Diagnostics and Therapeutics Industry Dynamic
2.3.1 Chlamydia Infection Diagnostics and Therapeutics Market Trends
2.3.2 Chlamydia Infection Diagnostics and Therapeutics Market Drivers
2.3.3 Chlamydia Infection Diagnostics and Therapeutics Market Challenges
2.3.4 Chlamydia Infection Diagnostics and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chlamydia Infection Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Chlamydia Infection Diagnostics and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chlamydia Infection Diagnostics and Therapeutics Revenue
3.4 Global Chlamydia Infection Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chlamydia Infection Diagnostics and Therapeutics Revenue in 2020
3.5 Chlamydia Infection Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Chlamydia Infection Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Chlamydia Infection Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chlamydia Infection Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Chlamydia Infection Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Chlamydia Infection Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)
5 Chlamydia Infection Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Chlamydia Infection Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Chlamydia Infection Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chlamydia Infection Diagnostics and Therapeutics Market Size (2016-2027)
6.2 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
6.2.1 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2027)
6.3 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application
6.3.1 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2027)
6.4 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country
6.4.1 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size (2016-2027)
7.2 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
7.2.1 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application
7.3.1 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Country
7.4.1 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size (2016-2027)
9.2 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
9.2.1 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application
9.3.1 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country
9.4.1 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bio Rad
11.1.1 Bio Rad Company Details
11.1.2 Bio Rad Business Overview
11.1.3 Bio Rad Chlamydia Infection Diagnostics and Therapeutics Introduction
11.1.4 Bio Rad Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.1.5 Bio Rad Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Chlamydia Infection Diagnostics and Therapeutics Introduction
11.2.4 Novartis Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Chlamydia Infection Diagnostics and Therapeutics Introduction
11.3.4 Roche Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Chlamydia Infection Diagnostics and Therapeutics Introduction
11.4.4 Abbott Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Chlamydia Infection Diagnostics and Therapeutics Introduction
11.5.4 Danaher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.5.5 Danaher Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Details
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Chlamydia Infection Diagnostics and Therapeutics Introduction
11.6.4 BioMerieux Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.6.5 BioMerieux Recent Development
11.7 DiaSorin
11.7.1 DiaSorin Company Details
11.7.2 DiaSorin Business Overview
11.7.3 DiaSorin Chlamydia Infection Diagnostics and Therapeutics Introduction
11.7.4 DiaSorin Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.7.5 DiaSorin Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Chlamydia Infection Diagnostics and Therapeutics Introduction
11.8.4 Siemens Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.8.5 Siemens Recent Development
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Details
11.9.2 Thermo Fisher Business Overview
11.9.3 Thermo Fisher Chlamydia Infection Diagnostics and Therapeutics Introduction
11.9.4 Thermo Fisher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.9.5 Thermo Fisher Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Details
11.10.2 Becton Dickinson Business Overview
11.10.3 Becton Dickinson Chlamydia Infection Diagnostics and Therapeutics Introduction
11.10.4 Becton Dickinson Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
11.10.5 Becton Dickinson Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chlamydia Infection Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nucleic Acid Amplification Tests (NAATs)
Table 3. Key Players of Direct Fluorescent Tests
Table 4. Key Players of Macrolides
Table 5. Key Players of Quinolones
Table 6. Key Players of Sulfonamides
Table 7. Key Players of Tetracycline
Table 8. Key Players of Aminopenicillins
Table 9. Global Chlamydia Infection Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Chlamydia Infection Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Table 15. Chlamydia Infection Diagnostics and Therapeutics Market Trends
Table 16. Chlamydia Infection Diagnostics and Therapeutics Market Drivers
Table 17. Chlamydia Infection Diagnostics and Therapeutics Market Challenges
Table 18. Chlamydia Infection Diagnostics and Therapeutics Market Restraints
Table 19. Global Chlamydia Infection Diagnostics and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Chlamydia Infection Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chlamydia Infection Diagnostics and Therapeutics as of 2020)
Table 22. Ranking of Global Top Chlamydia Infection Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Chlamydia Infection Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chlamydia Infection Diagnostics and Therapeutics Product Solution and Service
Table 26. Date of Enter into Chlamydia Infection Diagnostics and Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Chlamydia Infection Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Chlamydia Infection Diagnostics and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Chlamydia Infection Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Bio Rad Company Details
Table 67. Bio Rad Business Overview
Table 68. Bio Rad Chlamydia Infection Diagnostics and Therapeutics Product
Table 69. Bio Rad Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bio Rad Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Chlamydia Infection Diagnostics and Therapeutics Product
Table 74. Novartis Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Chlamydia Infection Diagnostics and Therapeutics Product
Table 79. Roche Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Chlamydia Infection Diagnostics and Therapeutics Product
Table 84. Abbott Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. Danaher Company Details
Table 87. Danaher Business Overview
Table 88. Danaher Chlamydia Infection Diagnostics and Therapeutics Product
Table 89. Danaher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Danaher Recent Development
Table 91. BioMerieux Company Details
Table 92. BioMerieux Business Overview
Table 93. BioMerieux Chlamydia Infection Diagnostics and Therapeutics Product
Table 94. BioMerieux Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 95. BioMerieux Recent Development
Table 96. DiaSorin Company Details
Table 97. DiaSorin Business Overview
Table 98. DiaSorin Chlamydia Infection Diagnostics and Therapeutics Product
Table 99. DiaSorin Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 100. DiaSorin Recent Development
Table 101. Siemens Company Details
Table 102. Siemens Business Overview
Table 103. Siemens Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Siemens Recent Development
Table 105. Thermo Fisher Company Details
Table 106. Thermo Fisher Business Overview
Table 107. Thermo Fisher Chlamydia Infection Diagnostics and Therapeutics Product
Table 108. Thermo Fisher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Thermo Fisher Recent Development
Table 110. Becton Dickinson Company Details
Table 111. Becton Dickinson Business Overview
Table 112. Becton Dickinson Chlamydia Infection Diagnostics and Therapeutics Product
Table 113. Becton Dickinson Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Becton Dickinson Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Nucleic Acid Amplification Tests (NAATs) Features
Figure 3. Direct Fluorescent Tests Features
Figure 4. Macrolides Features
Figure 5. Quinolones Features
Figure 6. Sulfonamides Features
Figure 7. Tetracycline Features
Figure 8. Aminopenicillins Features
Figure 9. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Diagnostic Centers Therapeutics Case Studies
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Drugstores Case Studies
Figure 15. Retail Pharmacies Case Studies
Figure 16. Online Pharmacies Case Studies
Figure 17. Chlamydia Infection Diagnostics and Therapeutics Report Years Considered
Figure 18. Global Chlamydia Infection Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Chlamydia Infection Diagnostics and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 21. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Figure 22. Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Players in 2020
Figure 23. Global Top Chlamydia Infection Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chlamydia Infection Diagnostics and Therapeutics as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Chlamydia Infection Diagnostics and Therapeutics Revenue in 2020
Figure 25. Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 26. Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 27. North America Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 29. North America Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 30. North America Chlamydia Infection Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 31. United States Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 35. Europe Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 36. Europe Chlamydia Infection Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 37. Germany Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Share by Region (2016-2027)
Figure 47. China Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 55. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 56. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 57. Mexico Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Chlamydia Infection Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 63. Turkey Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Chlamydia Infection Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Bio Rad Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 69. Abbott Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 70. Danaher Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 71. BioMerieux Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 72. DiaSorin Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 73. Siemens Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 74. Thermo Fisher Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 75. Becton Dickinson Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のクラミジア感染症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chlamydia Infection Diagnostics Market The global Chlamydia Infection Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界のクラミジア感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chlamydia Infection Therapeutics Market The global Chlamydia Infection Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界のクラミジア感染症検査市場規模・現状・予測（2021年-2027年） Chlamydia Infection Test is used to screen for, diagnose, and verify successful treatment of infections caused by the bacteria Chlamydia trachomatis. Market Analysis and Insights: Global Chlamydia Infection Test Market The global Chlamydia Infection Test market size is projected to reach US$ XX mill…
- 世界のクラミジア診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chlamydia Diagnosis and Treatment Market The global Chlamydia Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界のクラミジア診断検査市場規模・現状・予測（2021年-2027年） Chlamydia Diagnostic Testing is used to screen for, diagnose, and verify successful treatment of infections caused by the bacteria Chlamydia trachomatis. Market Analysis and Insights: Global Chlamydia Diagnostic Testing Market The global Chlamydia Diagnostic Testing market size is projected to reach…